Gamma

Manipal Health: Three Generations of the Pai Family and the Rise of India’s Hospital Empire

1. It is essential to clarify at the outset that Manipal Health does not have a single founder who can adequately represent its entire history. A more accurate interpretation is that the enterprise was built over three generations of the Pai family. The first generation, T. M. A. Pai, created the institutional foundation in education, healthcare and finance and founded Kasturba Medical College in 1953. The second generation, Ramdas Pai, converted that educational and medical ecosystem into a modern hospital business by establishing the Old Airport Road flagship hospital in Bengaluru in 1991. The third generation, Ranjan Pai, founded the Manipal Education and Medical Group, or MEMG, in 2000 and transformed the hospital business into a nationwide platform capable of accepting private equity, executing acquisitions, integrating regional chains and entering the public market. Manipal’s own materials trace the group’s roots to T. M. A. Pai and say that the legacy was advanced by Ramdas Pai and Ranjan Pai; TPG explicitly identifies Ramdas Pai as the founder of the modern Manipal Hospitals business in 1991. Therefore, if the question is who founded the broader Manipal institutional system, the answer is T. M. A. Pai. If the question is who founded the present-day Manipal Hospitals chain, the answer is primarily Ramdas Pai. If the question is who shaped the capitalized and nationwide Manipal Health of today, the central figure is Ranjan Pai. 2. T. M. A. Pai was born on India’s southwestern coast, far from the country’s traditional political and industrial centers. Tonse Madhava Ananth Pai is generally recorded as having been born on April 30, 1898, in the Udupi area of present-day Karnataka, into a Goud Saraswat Brahmin family that was not economically prominent. The coastal region in which he grew up had limited higher education, specialized healthcare and inclusive financial infrastructure. Young people seeking professional training usually had to leave the area. Public information about his parents, the precise scale of family wealth and the details of his childhood is limited and cannot presently be confirmed. Existing biographies, however, generally describe his environment as modest, local and resource-constrained rather than one based on an inherited industrial empire. This distinction is important. The Pai family’s initial advantage did not come from large industrial holdings, extensive land or colonial trading privileges. It came from professional education, community trust and the ability to build institutions. The hospitals, universities and financial networks that followed were responses to three local scarcities: education, healthcare and financing. 3. T. M. A. Pai began as a physician but soon concluded that individual medical practice alone could not transform the region. He studied medicine at Stanley Medical College in Madras and subsequently returned to the Udupi area to practice. Some historical accounts date the beginning of his local practice to 1925. His work as a doctor exposed him to the reinforcing relationship among disease, poverty, illiteracy and inadequate household savings: low-income families could not accumulate funds for healthcare or education, while inadequate education continued to constrain income and social mobility. This helps explain why he did not merely operate a clinic. He entered banking, education and hospital development because he viewed healthcare not as an isolated industry but as one component of a regional development system. 4. T. M. A. Pai’s first important commercial and social innovation was connected to inclusive savings and banking. He was involved in the establishment of the financial institution that later became Syndicate Bank and was closely associated with the “Pigmy Deposit Scheme,” under which bank representatives regularly collected very small deposits from customers. This enabled households with irregular incomes and no large surplus to enter the formal savings system. Pai later held senior banking responsibilities, and the resulting financial network contributed to the credit base on which local institutions could be built. The experience deeply influenced the later Manipal model: rather than waiting for one large government allocation, it organized fragmented demand, tuition payments, savings, professional talent and community trust into sustainable institutions. 5. The creation of Kasturba Medical College in 1953 was the true institutional starting point of the Manipal system. At the time, places in Indian medical schools were scarce and privately financed professional education remained unusual. T. M. A. Pai created Kasturba Medical College in Manipal using a model based on student fees, institutional reinvestment and the parallel development of teaching hospitals. Engineering, dentistry, nursing and other professional institutions followed, gradually turning Manipal from a small town into an education- and healthcare-centered university town. The significance went far beyond opening another medical school. It created a stable physician-training pipeline, teaching hospitals, research activity, campus infrastructure, a nationwide alumni network and the Manipal brand. The later hospital chain could draw on this accumulated talent, reputation and clinical teaching capacity. 6. T. M. A. Pai’s central philosophy can be described as using self-financing institutions to address deficiencies in social infrastructure. Official commemorative materials often describe the problems he confronted as poverty, illness and illiteracy. He was neither simply a philanthropist nor a conventional shareholder-value entrepreneur. He was an institutional entrepreneur who organized capital through banking, trained professionals through schools, created practical settings through hospitals and reinvested institutional revenue into further expansion. He received the Padma Shri in 1972. This model also created a structural feature that remains relevant: the Pai family’s nonprofit educational institutions, family holding companies, hospital operating businesses and brand-licensing entities are related but are not identical legal bodies. Any analysis of Manipal must distinguish the wider family ecosystem from the assets of the listed hospital company. 7. Ramdas Pai was the person who converted the family’s medical-education resources into a modern hospital-management system. Ramdas Madhava Pai is generally recorded as having been born on September 17, 1935, in Udupi, the son of T. M. A. Pai and Sharada Pai. He studied medicine at Kasturba Medical College and later undertook hospital-administration training in the United States. MAHE’s official profile states that he pursued postgraduate hospital-administration training at Albert Einstein Medical Center in Philadelphia. In 1961, he joined Kasturba Hospital as a hospital administrator. His career path differed from that of his father. T. M. A. Pai excelled at creating multiple kinds of institutions; Ramdas Pai focused more specifically on managing large hospitals and coordinating beds, clinical departments, physicians, equipment, finance and medical teaching. 8. In 1991, Ramdas Pai established Manipal Hospital on Old Airport Road in Bengaluru, launching the modern hospital chain. The flagship initially had approximately 650 beds and is listed in the later prospectus as having about 700 licensed beds. It was positioned as a multispecialty tertiary- and quaternary-care hospital. Choosing Bengaluru rather than remaining confined to the town of Manipal marked the group’s first systematic entry into a rapidly growing metropolitan commercial-healthcare market. This represented the first major commercial transformation in the family’s history: healthcare moved from being primarily an adjunct to the university and teaching system into a professionally managed hospital business capable of expanding independently, accepting commercial capital and serving urban middle-class and insured patients. 9. Ranjan Pai was born and raised in Manipal and was himself a product of the family’s institutional environment. He is the son of Ramdas Pai and the grandson of T. M. A. Pai. Public profiles generally state that he was born in Manipal. Forbes listed him as 53 years old in 2026; reliable public sources do not consistently state his exact birth date, so accounts differ and it cannot presently be confirmed. His background differed from that of a typical first-generation entrepreneur. He did not enter healthcare from outside the system. He grew up in a town organized around medical schools, hospitals, students, physicians and family-run institutions. This gave him an early view of how professional reputation is built, why hospitals require long-duration capital, and where family control can conflict with professional management. 10. Ranjan Pai received medical training but did not define his career around clinical practice. He graduated from Kasturba Medical College and subsequently completed a fellowship in hospital administration in the United States. Official sources do not identify the precise institution or full dates of the fellowship; public information is limited and cannot presently be confirmed. This choice determined his later position. He possessed the industry knowledge and professional legitimacy associated with medical training, but his main work became capital allocation, organizational design, mergers and acquisitions, and strategic management rather than treating patients. 11. Ranjan Pai’s first representative professional role was developing Melaka Manipal Medical College in Malaysia. EY and other public profiles state that he served early in his career as Managing Director of Melaka Manipal Medical College and participated in conceptualizing the cross-border medical-education venture. The project combined Indian medical-teaching capacity, Malaysian student demand and international program organization. The experience exposed him early to international regulation, education-brand replication, partnership-based academic programs and the commercialization of professional education. It also foreshadowed MEMG: Manipal would no longer be treated merely as a geographic location but as an institutional capability that could be replicated, invested in and exported. 12. Ranjan Pai’s establishment of MEMG in 2000 marked his transition from family successor to independent corporate architect. MAHE’s official profile describes him as founder and chairman of the Manipal Education and Medical Group and characterizes MEMG as a holding structure spanning healthcare, education, insurance, research and private investments. Forbes India reported that he began from a rented Bengaluru house with approximately $200,000 drawn from savings and borrowings; that initial-capital figure is a media account rather than a number from audited public-company financial statements. MEMG’s significance was not simply that it added another holding company. It separated commercial projects that had previously been intertwined with family trusts, universities and hospitals, creating a legal and governance platform capable of admitting investors, selling equity, establishing subsidiaries and executing acquisitions. English Translation: Hospital Network, Asset Structure and Business Model 13. The Manipal Hospitals brand dates to 1991, but the legal history of the present listed issuer is not identical to the brand’s operating history. The current legal entity, Manipal Health Enterprises Limited, was incorporated in 2010, converted from a private limited company to a public limited company in late 2025 and completed its IPO in 2026. Thus, “founded in 1991” refers to the operational origin of the hospital business and brand, while “incorporated in 2010” refers to the registered history of the principal present-day issuer. The two statements are not contradictory. This distinction matters because the group’s history, trademarks, teaching hospitals, university assets and listed-company consolidated accounts do not fully overlap. Not every school, hospital or foundation carrying the Manipal name is wholly owned by the listed hospital company. 14. As of March 2026, the prospectus described Manipal Health as India’s largest nationwide multispecialty hospital network by bed capacity. The company had 49 hospitals, including six operated under operations-and-management agreements, across 14 states and union territories. The prospectus listed 13,037 licensed beds and approximately 7.63 million patients served in fiscal 2026. The company website uses broader brand-level figures of more than 12,600 beds, more than eight million patients annually and more than 11,000 physicians. Public bed-count terminology is inconsistent. Parts of the website describe more than 12,600 beds as operational, while the prospectus distinguishes approximately 13,037 licensed beds from roughly 6,878 pro forma operational beds. For financial and capacity analysis, the prospectus definitions should take priority. Not every licensed bed should be treated as an operating, revenue-generating bed. 15. The hospital system has evolved from a southern Indian core into a combination of regional platforms across southern, eastern and western India. Karnataka still contributed approximately 46.40% of operating revenue in fiscal 2026, but that proportion had fallen from roughly 59.98% in fiscal 2024, indicating that acquisitions were reducing dependence on Bengaluru and the home state. Licensed capacity included approximately 6,404 beds in Karnataka, 2,188 across Maharashtra and Goa, and 2,887 in eastern India. The geographic structure is not yet a perfectly balanced national network. Core cash flow, physician reputation and management capability remain strongly anchored in southern India. Whether the eastern and western assets can reach the profitability of mature flagship hospitals remains an important integration variable. 16. Key tangible assets include major flagship hospitals, regional hospital clusters, medical equipment and equity interests in subsidiaries. The Old Airport Road hospital in Bengaluru has approximately 700 licensed beds and is the historical flagship of the modern chain. Kasturba Hospital in Manipal has about 2,235 licensed beds and is one of the largest teaching and management-partnership facilities. The EM Bypass hospital in Kolkata has about 500 licensed beds. The prospectus also disclosed 18 soft-tissue robotic systems, 19 linear accelerators, 44 MRI machines, 23 orthopedic or spine robotic systems, 58 catheterization laboratories, two tomotherapy systems and six gamma cameras. These constitute the “hard assets” that directly create clinical capacity, revenue and financing value. However, some facilities may be held through leases, management agreements or subsidiary structures, so total beds should not be interpreted as real estate directly owned by the listed company. 17. The teaching-hospital and university ecosystem is one of Manipal’s most difficult structural advantages to replicate. Institutions such as Kasturba Hospital perform patient-care, clinical-training and medical-education functions simultaneously. Manipal Health operates some of these hospitals under O&M arrangements and may not own all the underlying land or assets, while taking responsibility for clinical, staffing or operational management. The prospectus confirms that six of the 49 hospitals are O&M facilities. This allows the group to obtain hospital capacity, case volume and clinical-training environments with less direct asset investment. More importantly, Kasturba Medical College and MAHE provide a long-term talent environment. The advantage is not that the university supplies the listed company with free doctors; it is that brand reputation, alumni relationships, teaching credibility and recruitment channels create a durable network effect. 18. The Manipal name is an important influence asset, but its legal ownership and use are more complex than they appear. Material-contract disclosures in the IPO documentation show brand-licensing arrangements involving the listed company, certain subsidiaries and group entities including MEMG International India. This indicates that the operating hospital issuer does not simply and unconditionally own all Manipal intellectual property across the wider family ecosystem; relevant brand rights are used through intra-group licensing arrangements. The distinction affects how assets should be understood. Hospital equity interests, equipment, cash flows and bed licenses are relatively identifiable operating assets. The Manipal name, medical-school history, family reputation, alumni network and physician trust are influence assets. They are highly valuable, but their value depends on continued licensing, reputation protection and coordination across the family ecosystem. 19. Beyond hospitals, the group is developing diagnostic, outpatient, home-care and digital access points. Official materials describe an integrated service range covering outpatient care, diagnostics, complex inpatient treatment and personalized home care. Diagnostic brands such as Manipal HealthMap and ManipalTRUtest extend the imaging, pathology and regional testing network. Some centers use partnership or franchise structures, reducing the capital required relative to building full-scale hospitals. The strategic value of these businesses is that they reach patients earlier, channel diagnostic cases into hospitals, generate non-inpatient revenue and extend the brand into cities without major hospitals. Public disclosures do not yet show that diagnostics has become a profit center equal in scale to inpatient care. 20. Manipal Health’s core business model remains high-complexity inpatient medicine, rather than content, consulting or simple brand licensing. The company emphasizes six specialty groups summarized as “CONGO-R”: cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics and renal sciences. These specialties generated approximately 64.30% of gross inpatient revenue in fiscal 2026. Complex surgery, intensive care, oncology, transplantation and interventional procedures require advanced equipment and multidisciplinary physician teams and generally produce higher revenue per case. Revenue growth depends primarily on five variables: the number of operational beds, occupancy, average revenue per occupied bed or ARPOB, average length of stay or ALOS, and the proportion of high-value specialty cases. Acquisitions increase geographic reach and bed capacity; brand and referral networks raise occupancy; advanced specialties increase ARPOB; and process improvement can reduce length of stay while maintaining clinical quality. 21. The payer mix shows that Manipal is deeply dependent on insurers, third-party administrators and government programs. In fiscal 2026, insurers and TPAs accounted for approximately 49.68% of revenue, government programs for about 13.80%, other payers for approximately 6.19%, and cash-paying patients for roughly 30.33%. Insurance improves patients’ ability to afford complex treatment and can increase case volume, but it creates price negotiation, claims review, collection-cycle and denial risks. Government programs can generate substantial volume but typically offer lower tariffs. The company therefore must manage not only patient volumes but also contracted rates, collection periods, specialty mix and costs. 22. Operating metrics show substantial scale but uneven maturity across the network. In fiscal 2026, the group had approximately 6,878 pro forma operational beds, occupancy of about 64.47%, ARPOB of approximately ₹68,938 per day and an average length of stay of about 2.78 days. It recorded roughly 5.48 million outpatient visits, about 527,000 inpatients and approximately 24,240 employees. Occupancy near 64% indicates additional utilization potential within existing operational capacity. Newly built or acquired hospitals, however, normally require time to recruit physicians, migrate brands, sign insurer contracts and establish referral channels, so utilization below mature flagship levels may persist during integration. 23. The financial profile is characteristic of an acquisition-led platform: rapid revenue expansion accompanied by pressure on net profit and leverage. In fiscal 2026, operating revenue was approximately ₹10,335.75 crore, total income approximately ₹10,520.52 crore, EBITDA approximately ₹2,721.87 crore and net profit approximately ₹916.52 crore. In fiscal 2025, operating revenue was approximately ₹8,242.25 crore, EBITDA approximately ₹2,261.02 crore and net profit approximately ₹1,081.67 crore. Revenue and EBITDA therefore increased, while net profit declined. Total borrowings were approximately ₹10,553.43 crore in fiscal 2026, while net debt to adjusted EBITDA rose to about 3.74 times from roughly 2.00 times in the preceding year. Growth has not been costless: hospital acquisitions require equity consideration, assumption or refinancing of liabilities, facility upgrades and interest and depreciation during integration. English Translation: Acquisitions, Capital Relationships, Turning Points and Controversies 24. Ranjan Pai’s most important judgment about the hospital industry was that hospitals require long-duration capital and that ownership should be separated from day-to-day management. In a public interview, he explained that the family wanted capital capable of supporting the long development cycle of hospitals while allowing professional executives to operate the company rather than having family members control every daily decision. Ranjan Pai now acts primarily as a promoter, non-executive director and capital allocator. Dilip Jose serves as Managing Director and CEO, while H. Sudarshan Ballal is board chairman. This decision changed Manipal’s organizational character. It retains the family name and strategic influence but is no longer a conventionally family-owned company in which founder relatives personally manage every hospital. 25. TPG’s investment in 2015 was the first decisive turning point in the capitalization of the hospital business. TPG invested approximately ₹900 crore for a significant minority position. The capital added expansion capacity and introduced the disciplines commonly associated with private equity: independent governance, financial metrics, return requirements, acquisition frameworks and eventual exit planning. Ranjan Pai’s crucial role was not merely finding an investor. He accepted dilution of family ownership and placed the company under external institutional oversight. This prepared the governance structure for Temasek’s later control and the IPO. 26. The attempted acquisition of Fortis Healthcare in 2018 was one of the group’s most important failed projects. Manipal and TPG proposed combining the Manipal hospital business with Fortis’s hospital operations, potentially creating one of India’s largest healthcare providers. The initial structure faced opposition from Fortis minority shareholders, who considered the valuation too low; Fortis shares fell by approximately 14% after the announcement. Manipal later improved its offer but ultimately did not secure control, and Fortis entered a different acquisition process. The failure exposed a weakness in the Ranjan Pai model: a complex share-swap transaction must not only have industrial logic but also satisfy the target’s minority shareholders on valuation and control. At the same time, the bid demonstrated that Manipal no longer intended to remain a regional operator and was prepared to pursue a transaction capable of reshaping the national market. 27. After the Fortis failure, Manipal shifted toward more controllable, phased acquisitions, with substantially better results. In 2021, the company acquired Columbia Asia’s 11 Indian hospitals and related operations and gradually rebranded them under Manipal. It also acquired Vikram Hospital in Bengaluru that year. Columbia Asia added assets in Bengaluru, Pune, Kolkata, Ghaziabad and other markets, giving Manipal rapid nationwide reach without the complexity of merging with a publicly listed target such as Fortis. The approach reflected an evolution in acquisition strategy: instead of attempting to buy an entire national platform in one transaction, Manipal acquired hospital portfolios that could be separately valued and integrated city by city. 28. Acquisitions from 2023 through 2025 completed major parts of the eastern and western regional network. In 2023, Manipal acquired control of AMRI Hospitals, strengthening its position in Kolkata and eastern India. In 2024, it acquired control of Medica Synergie; the transaction brought approximately 1,200 beds and a large clinical workforce into the network. In 2025, it acquired Sahyadri Hospitals in Maharashtra, creating a significant Pune and western India platform. There is a clear continuity among these transactions. Columbia Asia provided a multi-city base; AMRI and Medica created density in the east; Sahyadri created density in the west. The objective is not merely to own dispersed hospitals but to develop multi-facility clusters in priority cities that can share physicians, branding, procurement and referrals. 29. Temasek’s acquisition of control in 2023 was the fundamental turning point in family ownership. Temasek spent approximately $2 billion to acquire an additional 41%, raising its stake to roughly 59% and valuing Manipal Health at about $5 billion. Public accounts described the immediate post-transaction ownership as approximately 59% Temasek, 30% Manipal Group and 11% TPG. The Pai family thus voluntarily gave up majority ownership in exchange for global sovereign capital, acquisition capacity and a higher institutional valuation. One of Ranjan Pai’s defining commercial characteristics is that he appears to value expansion of the overall platform and preservation of strategic influence more than maintaining family ownership above 51%. 30. The capital structure became still more institutional in 2024 when Temasek sold approximately 8% to new long-term investors while retaining a majority position. The incoming investors included Abu Dhabi’s Mubadala, Novo Holdings and the California Public Employees’ Retirement System, or CalPERS. They respectively represent sovereign capital, long-duration life-sciences capital and a major public pension institution. This shareholder group shows that Manipal had moved from an “Indian family plus one private-equity fund” structure to an internationally held healthcare-infrastructure platform. The 59% figure from 2023 was a point-in-time post-transaction figure and should not be mechanically treated as the final ownership percentage after the 2026 IPO. 31. The principal purpose of the 2026 IPO was not to enable Ranjan Pai to cash out and leave, but to repair the post-acquisition balance sheet. The offering totaled approximately ₹9,275.22 crore, including roughly ₹8,000 crore of newly issued shares, with the balance consisting of sales by existing shareholders. The prospectus allocated approximately ₹5,552.76 crore to debt repayment, about ₹574 crore to purchasing a minority interest in Sahyadri and the remainder to general corporate purposes. The use of proceeds reveals the full cycle of the model: private capital supports acquisitions, debt enables transactions to close rapidly, and the IPO converts part of that leverage into permanent equity. Following deployment of IPO proceeds, the company expected a significant reduction in net debt. It also planned to invest about ₹4,000 crore over three to four years to add roughly 2,400 beds. 32. The stock performed strongly on its first trading day, although investor opinion on valuation remained divided. On August 5, 2026, the shares opened at approximately ₹655 on the BSE and ₹652 on the NSE, about 11% above the ₹590 offer price. The market valued the company at approximately $9.03 billion during the debut. The IPO was subscribed about 4.92 times overall; the institutional portion was subscribed approximately 8.25 times, while the retail portion reached only about 0.93 times and was not fully subscribed. Published valuation calculations differ. Depending on whether analysts use forecast, diluted or adjusted earnings, estimates range from approximately 75.9 to 84.65 times earnings. Although the precise multiple varies by methodology, the common conclusion is that the company was priced at a clear premium to most listed Indian hospital peers and that substantial growth expectations were already reflected in the valuation. 33. Ranjan Pai’s capital network now extends well beyond hospitals and universities. He co-founded Aarin Capital with former Infosys CFO T. V. Mohandas Pai, investing in education, healthcare, technology and other growth companies. Although they share the Pai surname, that fact alone does not establish that they are close relatives. Aarin’s official materials describe Ranjan Pai as the founder of MEMG and an important architect of Manipal Hospitals’ transformation. He also allocates private-market capital through family-office vehicles such as Claypond Capital. Media reports state that Claypond planned to manage or deploy more than $300 million and has been building a professional investment team. Ranjan Pai should therefore now be understood not simply as a hospital entrepreneur but as a cross-sector capital allocator using education and healthcare wealth, family assets and co-investment networks. 34. The Aakash and Byju’s transactions illustrate the higher-risk side of his investment style. In 2023, a family office associated with Ranjan Pai acquired debt exposure connected to Aakash Educational Services from creditors including Davidson Kempner, in a transaction reported at approximately ₹1,400 crore. He subsequently became one of Aakash’s most important, and reportedly largest, shareholders. Severe liquidity and governance problems at Byju’s parent Think & Learn complicated the associated loans, Aakash shares and arbitration proceedings. These interests are not core operating assets of Manipal Hospitals and should not be treated as problems belonging directly to the listed hospital company. They form part of the wider Ranjan Pai/MEMG family-capital network. The episode nevertheless shows that his role has expanded from operating established institutions to using debt, equity and negotiation to acquire influence or control in distressed assets. 35. Manipal’s most exceptional achievement is the conversion of a local education-and-healthcare system into a national hospital-consolidation platform. T. M. A. Pai created medical education and community institutions; Ramdas Pai created the metropolitan flagship hospital; Ranjan Pai completed three structural shifts: from a single hospital to a network, from family funding to global institutional capital, and from organic construction to systematic acquisitions. By 2026, Manipal had become India’s largest nationwide multispecialty hospital network by bed capacity and one of the highest-revenue private hospital groups. What it changed was not medical theory but the organizational path of Indian private healthcare. A medical school and teaching-hospital system could become a talent base; regional hospitals could be integrated through a common brand and capital structure; and a family could surrender majority ownership while preserving founder influence. 36. The principal controversies concern capital structures, valuation and governance rather than a distinctive medical doctrine advanced by the founder. In 2017, reporting based on the Paradise Papers described documents involving Ranjan Pai and related Mauritius entities used in financing and collateral arrangements. The existence of offshore entities is not itself evidence of illegality, and the cited material does not establish a criminal offense. The disclosures nevertheless prompted questions about complex cross-border structures, tax transparency and family-business financing. The Fortis proposal was criticized for undervaluing the target and inadequately balancing control and minority-shareholder interests. The 2026 IPO was criticized for its premium valuation, elevated leverage, declining occupancy and possible underestimation of integration risk. The central criticism of Ranjan Pai is therefore not an inability to expand, but the possibility that his use of capital and expansion can become excessively aggressive. 37. The company has also faced medical-liability and minority-shareholder disputes, which must be distinguished from the founder’s personal conduct. In a case originating from a 2003 treatment episode, India’s Supreme Court directed the Old Airport Road hospital to pay ₹10 lakh plus applicable interest in connection with harm including the patient’s loss of voice after anesthesia or treatment. This was an adverse medical-liability judgment against the hospital; it does not mean that Ranjan Pai personally committed medical negligence. In 2026, several U.S.-based minority shareholders in Manipal Hospitals Synergie alleged governance failures, dilution and unfulfilled commitments and sought approximately ₹32.25 crore. Manipal denied wrongdoing and argued that the dispute related to earlier shareholders or prior transaction arrangements. The matter remains an allegation and legal dispute, and final responsibility cannot presently be confirmed. 38. The company’s most practical future risks are the simultaneous constraints of acquisition integration, debt, physician retention, insurer bargaining and clinical quality. The prospectus identifies acquisition integration, medical-negligence litigation, regulatory licenses, brand reputation, insurer and TPA collections, government pricing, loss of key doctors and biomedical-waste compliance among its risks. Geographic concentration also remains material, with Karnataka still generating nearly half of revenue. Forty-nine hospitals and more than 13,000 licensed beds do not automatically guarantee high returns. Value will depend on whether new beds become operational, acquired hospitals improve utilization, physicians remain with the organization, insurer reimbursement covers costs, and rapid expansion can occur without serious quality or reputation failures. English Translation: Current Position, Key Years and Final Assessment 39. As of August 5, 2026, Ranjan Pai’s practical role is best understood as that of an institution builder and capital allocator rather than a hospital CEO. He is chairman of MEMG/Manipal Group, President of MAHE, a promoter and important non-executive figure in Manipal Health, and an investor in private markets through Aarin Capital, Claypond Capital and other family vehicles. Day-to-day hospital operations are primarily handled by professional executives including Dilip Jose. His influence comes from the combination of four resources: the Pai family’s century-long institutional reputation, medical and educational branding, influence over hospital equity and capital relationships, and the ability to connect with international investment institutions. He may not determine the clinical workflow of every hospital, but he can influence capital allocation, control structures and the direction of the next round of industry consolidation. 40. The identity changes across three Pai generations form a clear progression. T. M. A. Pai was a physician, banker, educationist and local institutional entrepreneur. Ramdas Pai was a medically trained hospital administrator and founder of the modern chain. Ranjan Pai is a medically trained holding-company founder, acquisition sponsor and investor. Medical education connects the three generations; the principal operating tool changes from community institutions to professional management and ultimately to global capital markets. 41. The key timeline is as follows. T. M. A. Pai was born in 1898; he returned to coastal Karnataka to practice medicine in the 1920s and later participated in building banking and small-savings institutions. He founded Kasturba Medical College in 1953. Ramdas Pai began managing Kasturba Hospital in 1961. The Bengaluru flagship opened in 1991. Ranjan Pai established MEMG in 2000. TPG invested in 2015. The Fortis acquisition attempt failed in 2018. Manipal acquired Columbia Asia India and Vikram Hospital in 2021. Temasek increased its stake to approximately 59% in 2023, the same year Manipal acquired control of AMRI. Mubadala, Novo Holdings and CalPERS entered in 2024, when Manipal also acquired Medica. Sahyadri was acquired in 2025. Manipal completed its IPO in 2026 and listed on August 5. 42. The most accurate final description of Manipal Health is a national hospital platform that uses an education-and-healthcare legacy as its trust base and acquisitions and institutional capital as its expansion tools. It is neither simply a family hospital business nor merely a collection of assets assembled by private-equity funds. The family contributes the name, history, medical-education relationships and long-term direction. Professional executives provide operations. Temasek, TPG, Mubadala, Novo Holdings, CalPERS and the public market provide capital. Regional hospital groups provide beds and local physician networks. Ranjan Pai’s greatest success has been his willingness to surrender equity control in exchange for a larger platform. The largest potential weakness arises from the same decision: once scale, debt, valuation and multi-layered shareholder relationships increase, any integration failure or clinical-quality problem is magnified. His position in the real world is not that of an inventor of a particular medical treatment, but of one of the most important institutional entrepreneurs operating at the intersection of education, healthcare and private capital in contemporary India.